Metabolomics:A useful tool for ischemic stroke research
10.1016/j.jpha.2023.05.015
- Author:
Wentao LI
1
;
Chongyu SHAO
;
Chang LI
;
Huifen ZHOU
;
Li YU
;
Jiehong YANG
;
Haitong WAN
;
Yu HE
Author Information
1. School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou,310053,China
- Keywords:
Metabolomics;
Ischemic stroke;
Biomarker;
Precision medicine;
Single cell metabolomics
- From:
Journal of Pharmaceutical Analysis
2023;13(9):968-983
- CountryChina
- Language:Chinese
-
Abstract:
Ischemic stroke(IS)is a multifactorial and heterogeneous disease.Despite years of studies,effective strategies for the diagnosis,management and treatment of stroke are still lacking in clinical practice.Metabolomics is a growing field in systems biology.It is starting to show promise in the identification of biomarkers and in the use of pharmacometabolomics to help patients with certain disorders choose their course of treatment.The development of metabolomics has enabled further and more biological appli-cations.Particularly,metabolomics is increasingly being used to diagnose diseases,discover new drug targets,elucidate mechanisms,and monitor therapeutic outcomes and its potential effect on precision medicine.In this review,we reviewed some recent advances in the study of metabolomics as well as how metabolomics might be used to identify novel biomarkers and understand the mechanisms of IS.Then,the use of metabolomics approaches to investigate the molecular processes and active ingredients of Chinese herbal formulations with anti-IS capabilities is summarized.We finally summarized recent developments in single cell metabolomics for exploring the metabolic profiles of single cells.Although the field is relatively young,the development of single cell metabolomics promises to provide a powerful tool for unraveling the pathogenesis of IS.
